{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Horsham",
      "address_1": "2 Walnut Grove Dr",
      "reason_for_recall": "Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.",
      "address_2": "Suite 190",
      "product_quantity": "12,948 bottles",
      "code_info": "Lot 220839, exp 11/30/2013",
      "center_classification_date": "20130227",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "state": "PA",
      "product_description": "Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-328-09",
      "report_date": "20130306",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Amedra Pharmaceuticals LLC",
      "recall_number": "D-172-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "63926",
      "termination_date": "20140321",
      "recall_initiation_date": "20121204",
      "postal_code": "19044-2219",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}